NCT02365662 2018-03-30A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorAbbViePhase 1 Terminated46 enrolled
NCT01800695 2017-11-21Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma MultiformeAbbViePhase 1 Completed202 enrolled